Enzo Biochem (ENZ) reported Loss for first quarter that decreased from the same period last year
The company's bottom line came in at -$3.38 million, or -$0.07 per share. This compares with -$6.62 million, or -$0.13 per share, in last year's first quarter.
Excluding items, Enzo Biochem reported adjusted earnings of -$2.53 million or -$0.05 per share for the period.
The company's revenue for the quarter fell 20.5% to $6.21 million from $7.81 million last year.
Enzo Biochem earnings at a glance (GAAP) :
-Earnings (Q1): -$3.38 Mln. vs. -$6.62 Mln. last year.-EPS (Q1): -$0.07 vs. -$0.13 last year.-Revenue (Q1): $6.21 Mln vs. $7.81 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.